Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

EMAMILTD · NSE

Emami

₹372.65

▼ -1.69%

Close (EOD), as of 1 Oct 2026 · source

Not in active coverage. Cited reporting has mentioned Emami, the record of those mentions is below. Your interest is logged; coverage expands by demand.

Mentions in cited reporting

Emami's Himani Best Choice is targeting Rs 15,000 crore in brand revenues over the next three to five years.

indiatimes.comsingle-source report22 Sep 2026

Emami's board has approved a share buyback of up to ₹282 crore through the open market route at a maximum price of ₹475 per equity share.

payoutthehindubusinessline.comcapitalmarket.comcorroborated · 2 sources17 Sep 2026

Emami Limited's BoroPlus has entered the baby-care category with the launch of BoroPlus FromMaa, a seven-product range enriched with premium natural ingredients including Mamra Almonds, Kashmiri Kesar and Milk Protein.

outlookbusiness.comsingle-source report8 Sep 2026

FMCG major Emami Ltd on Tuesday announced the launch of “BoroPlus FromMaa”, a new baby-care range.

thehindubusinessline.comsingle-source report8 Sep 2026

Emami's founder stated that the company is structurally positioned to benefit from expected recovery in rural demand and prevailing premiumisation trend in urban markets, supported by favorable monsoon conditions, improving agricultural output, and rising affordability.

indiatimes.comsingle-source report26 Aug 2026

Every claim carries its citation

This page lists where cited reporting has mentioned Emami. It is not the full dossier: developments here are single mentions, not corroborated records. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.